JFNCX Mutual Fund (Janus Henderson Global Life Sciences Fund Class C) is managed by Janus Henderson Investors with $163.5M in net assets. JFNCX expense ratio is 1.79%, holding 109 positions across sectors including Health Care, Unknown, Other. Inception date: 2009-07-06.

JFNCX performance shows a YTD return of 8.07%. The 1-year return is 38.20% and the 5-year return is 7.53%. JFNCX dividend yield stands at 4.58%, paid annually.

JFNCX top holdings include Eli Lilly And Company (9.7%), JOHNSON AND JOHNSON (5.6%), Astrazeneca Plc Adr (4.3%), Unitedhealth Group, Inc. (3.4%), Abbvie Inc Health Care (3.4%). View all JFNCX holdings, sector breakdown, or dividend history.

JFNCX can be compared against other funds using the overlap calculator or side-by-side comparison tool. JFNCX alternatives are available via the screener, along with tax-loss harvesting opportunities.